Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus
Authors:
- Su-Mi KimSKSu-Mi Kim
- Kwang-Nyeong LeeKLKwang-Nyeong Lee
- Su-Jung LeeSLSu-Jung Lee
- Young-Joon KoYKYoung-Joon Ko
- Hyang-Sim LeeHLHyang-Sim Lee
- Chang-Hee KweonCKChang-Hee Kweon
- Hyun-Soo KimHKHyun-Soo Kim
- Jong-Hyeon ParkJPJong-Hyeon Park
- 1 September 2010
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 87 (3) , 307-317
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Small Interfering RNA against Transcription Factor STAT6 Inhibits Allergic Airway Inflammation and Hyperreactivity in MiceThe Journal of Immunology, 2009
- siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infectionJournal of Drug Targeting, 2008
- Combinatorial RNAi: A Winning Strategy for the Race Against Evolving Targets?Molecular Therapy, 2007
- Silencing of HIV-1 with RNA Interference: a Multiple shRNA ApproachMolecular Therapy, 2006
- Optimization and Functional Effects of Stable Short Hairpin RNA Expression in Primary Human Lymphocytes via Lentiviral VectorsMolecular Therapy, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- Inhibition of Hepatitis B virus gene expression by single and dual small interfering RNA treatmentVirus Research, 2005
- Amplification of RNAi—Targeting HLA mRNAsMolecular Therapy, 2005
- Control of HIV-1 replication by RNA interferenceVirus Research, 2004
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994